Advertisement

Topics

Argenta Discovery Company Profile

18:01 EDT 23rd September 2017 | BioPortfolio

Argenta Discovery is a new United Kingdom-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series. Argenta comprises a mix of scientists skilled in computer-aided drug design, medicinal and combinatorial chemistry, and assay development and automated biochemical screening, forming one team for the in vitro optimisation of candidates.

Argenta Discovery is also actively working on its own projects for which patentable lead series will be available for sale or license. Argenta has a contract with Imperial College of Science, Technology and Medicine in London for First Right of Refusal for targets from several research groups.

Location

Rainham Road South
Dagenham
Essex
RM10 7XS
United Kingdom

Contact

Phone: +44-20-8919-3421
Fax: +44-20-8919-3859
Email: info@argentadiscovery.com


News Articles [446 Associated News Articles listed on BioPortfolio]

Consortium Applies Quantum Computing to Drug Discovery for Neurological Diseases

NewsMolecular comparison is a crucial part of early-phase drug design and discovery.

Sygnature Discovery partners on pancreatic cancer research

Sygnature Discovery, which claims to be the UK’s largest independent drug discovery expert and research…

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

Almac Discovery y Debiopharm International SA anuncian el desarrollo de un nuevo inhibidor Wee-1

Almac Discovery ( http://www.almacgroup.com/discovery), una compañía biofarmacéutica centrada en el descubrimiento e identificación de terapéuticos innovadores para el tratamiento del cáncer, ...

BioAscent Discovery Appoints New CEO And Announces Plans To Expand Discovery Services Offering

  Life Sciences Jobs   ...

Daiichi Sankyo in Drug Discovery Collaboration

Enters cancer research partnership with Max Planck Innovation and Lead Discovery Center

Zealand, Orbit Discovery enter into research collaboration

Zealand Pharma and Orbit Discovery have entered into a multi-target research collaboration to identify novel peptide therapeutics using Orbit’s proprietary peptide display technology. Zealand ha...

GlaxoSmithKline and Exscientia enter strategic drug discovery collaboration

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK). During t...

PubMed Articles [671 Associated PubMed Articles listed on BioPortfolio]

Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.

There was a greater than 50% decline in central nervous system (CNS) drug discovery and development programs by major pharmaceutical companies from 2009 to 2014. This decline was paralleled by a rise ...

Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment.

Epilepsy genetics is shifting from the academic pursuit of gene discovery to a clinical discipline based on molecular diagnosis and stratified medicine. We consider the latest developments in epilepsy...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease

Active discopathies or MODIC 1, are a diagnostic entity discovery with the contribution of MRI in which the first cases were described by Dr. Michael MODIC in 1988. It is characterized by ...

Companies [1058 Associated Companies listed on BioPortfolio]

Argenta Discovery

Argenta Discovery is a new United Kingdom-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scien...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "Argenta Discovery" on BioPortfolio

We have published hundreds of Argenta Discovery news stories on BioPortfolio along with dozens of Argenta Discovery Clinical Trials and PubMed Articles about Argenta Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argenta Discovery Companies in our database. You can also find out about relevant Argenta Discovery Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record